[
  {
    "ts": "2025-11-04T00:00:00+00:00",
    "headline": "AMD, Uber, Pfizer earnings on deck; ADP job data: What to Watch",
    "summary": "Yahoo Finance Senior Reporter Allie Canal outlines what investors are watching on Tuesday, Nov. 4. Pfizer (PFE), Uber (UBER), Spotify (SPOT), and BP (BP) are among the companies releasing earnings ahead of the opening bell. AMD (AMD), Pinterest (PINS), Rivian (RIVN), and Cava (CAVA) will continue the wave of earnings after the closing bell. ADP (ADP) is set to release a new weekly labor market report amid the ongoing government shutdown. Watch the video above to learn more about the stories that the market is watching. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
    "url": "https://finance.yahoo.com/video/amd-uber-pfizer-earnings-deck-000000165.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "f0ae64af-930b-3620-aa8b-1de6ad0420e4",
      "content": {
        "id": "f0ae64af-930b-3620-aa8b-1de6ad0420e4",
        "contentType": "VIDEO",
        "title": "AMD, Uber, Pfizer earnings on deck; ADP job data: What to Watch",
        "description": "<p>Yahoo Finance Senior Reporter <a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/author/alexandra-canal/\">Allie Canal</a> outlines what investors are watching on Tuesday, Nov. 4.</p>\n<p>Pfizer (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>), Uber (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/UBER\">UBER</a>), Spotify (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/SPOT\">SPOT</a>), and BP (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/BP\">BP</a>) are among the companies releasing earnings ahead of the opening bell.</p>\n<p>AMD (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/AMD\">AMD</a>), Pinterest (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/PINS\">PINS</a>), Rivian (<a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/quote/RIVN\">RIVN</a>), and Cava (<a data-i13n=\"cpos:9;pos:1\" href=\"https://finance.yahoo.com/quote/CAVA\">CAVA</a>) will continue the wave of earnings after the closing bell.</p>\n<p>ADP (<a data-i13n=\"cpos:10;pos:1\" href=\"https://finance.yahoo.com/quote/ADP\">ADP</a>) is set to release a new weekly labor market report amid the ongoing government shutdown.</p>\n<p>Watch the video above to learn more about the stories that the market is watching.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:11;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-domination-overtime/\">Market Domination Overtime</a>.</p>",
        "summary": "Yahoo Finance Senior Reporter Allie Canal outlines what investors are watching on Tuesday, Nov. 4. Pfizer (PFE), Uber (UBER), Spotify (SPOT), and BP (BP) are among the companies releasing earnings ahead of the opening bell. AMD (AMD), Pinterest (PINS), Rivian (RIVN), and Cava (CAVA) will continue the wave of earnings after the closing bell. ADP (ADP) is set to release a new weekly labor market report amid the ongoing government shutdown. Watch the video above to learn more about the stories that the market is watching. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.",
        "pubDate": "2025-11-04T00:00:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/e59eff70-b8fb-11f0-9ef9-61581d9584fe",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qd7P9mvHOGJOfJmPdlcmTA--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/e59eff70-b8fb-11f0-9ef9-61581d9584fe.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4NnABRvuo2ngzNtB06EEGw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/e59eff70-b8fb-11f0-9ef9-61581d9584fe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/amd-uber-pfizer-earnings-deck-000000165.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/amd-uber-pfizer-earnings-deck-000000165.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BP"
            },
            {
              "symbol": "BPAQF"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "CAVA"
            },
            {
              "symbol": "ADP"
            },
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "PINS"
            },
            {
              "symbol": "RIVN"
            },
            {
              "symbol": "UBER"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T21:27:14+00:00",
    "headline": "Earnings live: Pinterest stock tanks, AMD and Supermicro falter, Rivian pops amid flurry of Q3 reports",
    "summary": "Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
    "url": "https://finance.yahoo.com/news/live/earnings-live-pinterest-stock-tanks-amd-and-supermicro-falter-rivian-pops-amid-flurry-of-q3-reports-212714731.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "035a1404-14a9-4292-96b8-08cca27526ee",
      "content": {
        "id": "035a1404-14a9-4292-96b8-08cca27526ee",
        "contentType": "STORY",
        "title": "Earnings live: Pinterest stock tanks, AMD and Supermicro falter, Rivian pops amid flurry of Q3 reports",
        "description": "",
        "summary": "Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.",
        "pubDate": "2025-11-04T21:27:14Z",
        "displayTime": "2025-11-04T21:56:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/ea277b70-b9c4-11f0-a6ff-2a93fdc040f9",
          "originalWidth": 6580,
          "originalHeight": 4387,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JWmy.F.Ma_VBhK_3OhXDhg--~B/aD00Mzg3O3c9NjU4MDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ea277b70-b9c4-11f0-a6ff-2a93fdc040f9.cf.webp",
              "width": 6580,
              "height": 4387,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/go.GUb6lR4YIVTlbTtCuOQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ea277b70-b9c4-11f0-a6ff-2a93fdc040f9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-pinterest-stock-tanks-amd-and-supermicro-falter-rivian-pops-amid-flurry-of-q3-reports-212714731.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-pinterest-stock-tanks-amd-and-supermicro-falter-rivian-pops-amid-flurry-of-q3-reports-212714731.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "SMCI"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "RIVN"
            },
            {
              "symbol": "CEG"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "ARM"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "DUK"
            },
            {
              "symbol": "WEN"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "MAR"
            },
            {
              "symbol": "7203.T"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MCD"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "DASH"
            },
            {
              "symbol": "SNAP"
            },
            {
              "symbol": "AZN.L"
            },
            {
              "symbol": "COP"
            },
            {
              "symbol": "ABNB"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "XYZ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T13:15:21+00:00",
    "headline": "Earnings from Uber, Shopify, Spotify and Pfizer: Market Movers",
    "summary": "Uber (UBER) posted its strongest quarterly growth since late 2023 as customers ordered more rides and deliveries than expected. However, its share price fell in the premarket as its forecasts underwhelmed investors. Meanwhile Spotify's (SPOT) share price rose before the opening bell after the world's largest streaming service reported stronger-than-expected third-quarter results. Other results this morning include Shopify (SHOP) and pharmaceutical giant, Pfizer (PFE). For more live coverage of the markets, watch the full episode of Market Sunrise and visit Yahoo Finance.",
    "url": "https://finance.yahoo.com/video/earnings-uber-shopify-spotify-pfizer-131521696.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "bbe1608d-5fcf-3412-88c9-1bdee9866ffd",
      "content": {
        "id": "bbe1608d-5fcf-3412-88c9-1bdee9866ffd",
        "contentType": "VIDEO",
        "title": "Earnings from Uber, Shopify, Spotify and Pfizer: Market Movers",
        "description": "<p>Uber (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/UBER\">UBER</a>) posted its strongest quarterly growth since late 2023 as customers ordered more rides and deliveries than expected. However, its share price fell in the premarket as its forecasts underwhelmed investors. Meanwhile Spotify's (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/SPOT\">SPOT</a>) share price rose before the opening bell after the world's largest streaming service reported stronger-than-expected third-quarter results. Other results this morning include Shopify (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/SHOP\">SHOP</a>) and pharmaceutical giant, Pfizer (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>). For more live coverage of the markets, watch the full episode of <em>Market Sunrise</em> and visit<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/\"> Yahoo Finance</a>.</p>",
        "summary": "Uber (UBER) posted its strongest quarterly growth since late 2023 as customers ordered more rides and deliveries than expected. However, its share price fell in the premarket as its forecasts underwhelmed investors. Meanwhile Spotify's (SPOT) share price rose before the opening bell after the world's largest streaming service reported stronger-than-expected third-quarter results. Other results this morning include Shopify (SHOP) and pharmaceutical giant, Pfizer (PFE). For more live coverage of the markets, watch the full episode of Market Sunrise and visit Yahoo Finance.",
        "pubDate": "2025-11-04T13:15:21Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/d6f3a3a0-b97c-11f0-b7fb-998a083476dd",
          "originalWidth": 8192,
          "originalHeight": 4615,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/f6mItqk9Vch0fBQztlzHfA--~B/aD00NjE1O3c9ODE5MjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/d6f3a3a0-b97c-11f0-b7fb-998a083476dd.cf.webp",
              "width": 8192,
              "height": 4615,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pS9_2s1yBplDOM8WirKpNQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/d6f3a3a0-b97c-11f0-b7fb-998a083476dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/earnings-uber-shopify-spotify-pfizer-131521696.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/earnings-uber-shopify-spotify-pfizer-131521696.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "UBER"
            },
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "SHOP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T23:52:06+00:00",
    "headline": "Obesity Category Still Hot: Mizuho's Jared Holz",
    "summary": "Jared Holz, Mizuho Securities Healthcare Equity Strategist, says he wouldn't be surprised to see one more bid from Pfizer. He tells Katie Greifeld and Matt Miller on \"The Close\" that Pfizer made it clear without saying so directly that its latest attempt may not be the final one.",
    "url": "https://finance.yahoo.com/video/obesity-category-still-hot-mizuhos-235206313.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "6ea86560-2355-36ac-83a7-9232c7a2583f",
      "content": {
        "id": "6ea86560-2355-36ac-83a7-9232c7a2583f",
        "contentType": "VIDEO",
        "title": "Obesity Category Still Hot: Mizuho's Jared Holz",
        "description": "Jared Holz, Mizuho Securities Healthcare Equity Strategist, says he wouldn't be surprised to see one more bid from Pfizer. He tells Katie Greifeld and Matt Miller on \"The Close\" that Pfizer made it clear without saying so directly that its latest attempt may not be the final one.",
        "summary": "Jared Holz, Mizuho Securities Healthcare Equity Strategist, says he wouldn't be surprised to see one more bid from Pfizer. He tells Katie Greifeld and Matt Miller on \"The Close\" that Pfizer made it clear without saying so directly that its latest attempt may not be the final one.",
        "pubDate": "2025-11-04T23:52:06Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_markets_video_2/67dbbc86a769feef3d3dbd3bc4de9df1",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nLL85McsaHV9eIRkA.luQQ--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_video_2/67dbbc86a769feef3d3dbd3bc4de9df1.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MSanriygJVS_8NNb_8dJeQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_markets_video_2/67dbbc86a769feef3d3dbd3bc4de9df1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/obesity-category-still-hot-mizuhos-235206313.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/obesity-category-still-hot-mizuhos-235206313.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T23:45:03+00:00",
    "headline": "Stocks to Watch Tuesday: Palantir, Sarepta, Tesla",
    "summary": "↘️ Palantir (PLTR): Shares closed down 8%. The data-analytics company reported another quarter of record revenue but having more than doubled so far in 2025, the stock was priced for perfection. ↘️ Sarepta Therapeutics (SRPT): Shares tumbled 34% after the biotech company said results from a yearslong trial of two therapies for a rare muscle-wasting illness fell short of statistical significance.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-04-2025/card/stocks-to-watch-tuesday-palantir-sarepta-tesla-S4qnbrWmOoSc8RyFLX4A?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "44236e50-78c4-35b6-8779-45a28b55152c",
      "content": {
        "id": "44236e50-78c4-35b6-8779-45a28b55152c",
        "contentType": "STORY",
        "title": "Stocks to Watch Tuesday: Palantir, Sarepta, Tesla",
        "description": "",
        "summary": "↘️ Palantir (PLTR): Shares closed down 8%. The data-analytics company reported another quarter of record revenue but having more than doubled so far in 2025, the stock was priced for perfection. ↘️ Sarepta Therapeutics (SRPT): Shares tumbled 34% after the biotech company said results from a yearslong trial of two therapies for a rare muscle-wasting illness fell short of statistical significance.",
        "pubDate": "2025-11-04T23:45:03Z",
        "displayTime": "2025-11-04T23:45:03Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/44236e50-78c4-35b6-8779-45a28b55152c/stocks-to-watch-tuesday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/aee16748f6c9daf90bd432d2b369a13c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j.bbqtjxh69J4X7yha5EVw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/aee16748f6c9daf90bd432d2b369a13c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mhDxw7ZGLL3RzzPXre5kpg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/aee16748f6c9daf90bd432d2b369a13c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-04-2025/card/stocks-to-watch-tuesday-palantir-sarepta-tesla-S4qnbrWmOoSc8RyFLX4A?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "SRPT"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T22:10:00+00:00",
    "headline": "Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup",
    "summary": "The revised bids are the latest unusual twist in the fight between big drugmakers over drug developer Metsera.",
    "url": "https://www.wsj.com/health/pharma/novo-nordisk-sweetens-offer-for-metsera-e6dc4c2b?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "316478b2-e193-3894-aa94-9b93e8d7f4ca",
      "content": {
        "id": "316478b2-e193-3894-aa94-9b93e8d7f4ca",
        "contentType": "STORY",
        "title": "Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup",
        "description": "",
        "summary": "The revised bids are the latest unusual twist in the fight between big drugmakers over drug developer Metsera.",
        "pubDate": "2025-11-04T22:10:00Z",
        "displayTime": "2025-11-04T22:10:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/316478b2-e193-3894-aa94-9b93e8d7f4ca/pfizer-novo-nordisk-escalate.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/5f4febc280bd91c16dfba198c1eaa5c5",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ll4MUhearuiXh9G2Hd8MYQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/5f4febc280bd91c16dfba198c1eaa5c5.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9Einq.i1k8sNQW4L2my7yw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/5f4febc280bd91c16dfba198c1eaa5c5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/novo-nordisk-sweetens-offer-for-metsera-e6dc4c2b?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T21:51:00+00:00",
    "headline": "These Stocks Moved the Most Today: Palantir, Uber, Sarepta, Tesla, Norwegian Cruise Line, Hertz, AMD, and More",
    "summary": "Shares in data analytics software developer Palantir tumble even as the company tops analysts' earnings estimates.",
    "url": "https://www.barrons.com/articles/stock-movers-c6a73e9f?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "d40bc7cc-3bb4-3687-986c-7092c66c87d0",
      "content": {
        "id": "d40bc7cc-3bb4-3687-986c-7092c66c87d0",
        "contentType": "STORY",
        "title": "These Stocks Moved the Most Today: Palantir, Uber, Sarepta, Tesla, Norwegian Cruise Line, Hertz, AMD, and More",
        "description": "",
        "summary": "Shares in data analytics software developer Palantir tumble even as the company tops analysts' earnings estimates.",
        "pubDate": "2025-11-04T21:51:00Z",
        "displayTime": "2025-11-04T21:51:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d40bc7cc-3bb4-3687-986c-7092c66c87d0/these-stocks-moved-the-most.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/84b9aed704c1fe780e3a53b2d78ea946",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1A.Es8mvuG7i9lQ13shCjg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/84b9aed704c1fe780e3a53b2d78ea946.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DhPbTv5AXiRiB1Z.1WvLLg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/84b9aed704c1fe780e3a53b2d78ea946.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-c6a73e9f?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "SRPT"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "NCLH"
            },
            {
              "symbol": "HTZ"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T21:30:00+00:00",
    "headline": "Novo Nordisk Reports Earnings on Wednesday. What to Expect.",
    "summary": "The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more and more heated.",
    "url": "https://www.barrons.com/articles/novo-nordisk-earnings-stock-price-997bc7ca?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "ba684ec8-e1fe-37a7-b161-5472c35e891e",
      "content": {
        "id": "ba684ec8-e1fe-37a7-b161-5472c35e891e",
        "contentType": "STORY",
        "title": "Novo Nordisk Reports Earnings on Wednesday. What to Expect.",
        "description": "",
        "summary": "The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more and more heated.",
        "pubDate": "2025-11-04T21:30:00Z",
        "displayTime": "2025-11-04T21:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/ba684ec8-e1fe-37a7-b161-5472c35e891e/novo-nordisk-reports-earnings.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xyHlGWIyozQ11qgbu0Gisw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N2uBceIjOWjhcBVcyJWYqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/33cdf10977edf16fd4f87e8324176083.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/novo-nordisk-earnings-stock-price-997bc7ca?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AKRO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T21:18:28+00:00",
    "headline": "Pfizer Hikes Earnings Outlook Even As Third-Quarter Sales Decline",
    "summary": "Pfizer stock dipped early Tuesday despite hiking its 2025 profit guidance, as third-quarter sales and earnings both toppled year over year.",
    "url": "https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q3-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "9d18fb36-cfab-30d0-b0ce-e405952f4944",
      "content": {
        "id": "9d18fb36-cfab-30d0-b0ce-e405952f4944",
        "contentType": "STORY",
        "title": "Pfizer Hikes Earnings Outlook Even As Third-Quarter Sales Decline",
        "description": "",
        "summary": "Pfizer stock dipped early Tuesday despite hiking its 2025 profit guidance, as third-quarter sales and earnings both toppled year over year.",
        "pubDate": "2025-11-04T21:18:28Z",
        "displayTime": "2025-11-04T21:18:28Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/9d18fb36-cfab-30d0-b0ce-e405952f4944/pfizer-hikes-earnings-outlook.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/8a716db1a9187d7bf2bc1e8be3982d75",
          "originalWidth": 945,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fsBKs1ZYBb29b_f6IZRvqg--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/8a716db1a9187d7bf2bc1e8be3982d75.cf.webp",
              "width": 945,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SXW42BXOwOtnaZcm_tlLlQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/8a716db1a9187d7bf2bc1e8be3982d75.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q3-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T21:14:44+00:00",
    "headline": "Pfizer Inc (PFE) Q3 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...",
    "summary": "Despite a drop in COVID product demand, Pfizer Inc (PFE) surpasses EPS expectations and advances key strategic initiatives.",
    "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-q3-2025-211444003.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "ec1fddd4-6a72-38ae-a34b-cb5d40332f49",
      "content": {
        "id": "ec1fddd4-6a72-38ae-a34b-cb5d40332f49",
        "contentType": "STORY",
        "title": "Pfizer Inc (PFE) Q3 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...",
        "description": "",
        "summary": "Despite a drop in COVID product demand, Pfizer Inc (PFE) surpasses EPS expectations and advances key strategic initiatives.",
        "pubDate": "2025-11-04T21:14:44Z",
        "displayTime": "2025-11-04T21:14:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/3ef18f58b00ee3265d36c8798e99d659",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BmTh6ZYSp6W83ZDDYYcs5Q--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/3ef18f58b00ee3265d36c8798e99d659.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8fIxe6YHBozY7HF7LhM3qA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/3ef18f58b00ee3265d36c8798e99d659.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-inc-pfe-q3-2025-211444003.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T21:12:11+00:00",
    "headline": "Novo Sweetens Its Bid For Metsera As Takeover Drama With Pfizer Escalates",
    "summary": "Novo Nordisk said it would pay up to $10 billion to acquire obesity-focused Metsera, topping Pfizer's recently hiked $8.1 billion proposal.",
    "url": "https://www.investors.com/news/technology/novo-nordisk-metsera-pfizer-acquisition-battle/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "e655d65b-5b86-3308-8d1a-1120fcb033df",
      "content": {
        "id": "e655d65b-5b86-3308-8d1a-1120fcb033df",
        "contentType": "STORY",
        "title": "Novo Sweetens Its Bid For Metsera As Takeover Drama With Pfizer Escalates",
        "description": "",
        "summary": "Novo Nordisk said it would pay up to $10 billion to acquire obesity-focused Metsera, topping Pfizer's recently hiked $8.1 billion proposal.",
        "pubDate": "2025-11-04T21:12:11Z",
        "displayTime": "2025-11-04T21:12:11Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/e655d65b-5b86-3308-8d1a-1120fcb033df/novo-sweetens-its-bid-for.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/b9715ff1a750947c2a66c66577928376",
          "originalWidth": 1065,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LyR0Ezz6fO2zKMIemxL86w--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/b9715ff1a750947c2a66c66577928376.cf.webp",
              "width": 1065,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xkqimy.zH7QZX4upB8znuA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/b9715ff1a750947c2a66c66577928376.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/novo-nordisk-metsera-pfizer-acquisition-battle/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T20:59:31+00:00",
    "headline": "Sector Update: Health Care Stocks Rise Late Afternoon",
    "summary": "Health care stocks advanced late Tuesday afternoon with the NYSE Health Care Index and the Health Ca",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-205931993.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "0b853398-40a0-3747-a696-b15bf0dcc924",
      "content": {
        "id": "0b853398-40a0-3747-a696-b15bf0dcc924",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Rise Late Afternoon",
        "description": "",
        "summary": "Health care stocks advanced late Tuesday afternoon with the NYSE Health Care Index and the Health Ca",
        "pubDate": "2025-11-04T20:59:31Z",
        "displayTime": "2025-11-04T20:59:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-205931993.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-205931993.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RPRX"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "INSP"
            },
            {
              "symbol": "ALNY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T20:07:59+00:00",
    "headline": "How Pfizer's (PFE) Metsera Legal Fight and Q3 Dip Could Reshape Its Innovation Strategy",
    "summary": "On November 4, 2025, Pfizer reported third-quarter earnings showing a year-over-year decline in revenue to US$16.65 billion and net income to US$3.54 billion, while reaffirming full-year revenue guidance between US$61.0 billion and US$64.0 billion. The company's results reflect ongoing operational pressures, challenges related to COVID-19 product demand, and the impact of legal disputes over its bid for obesity drug developer Metsera. We'll explore how Pfizer's ongoing legal battle over the...",
    "url": "https://finance.yahoo.com/news/pfizers-pfe-metsera-legal-fight-200759583.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f34dce97-d515-36b3-a37b-f52121d2911f",
      "content": {
        "id": "f34dce97-d515-36b3-a37b-f52121d2911f",
        "contentType": "STORY",
        "title": "How Pfizer's (PFE) Metsera Legal Fight and Q3 Dip Could Reshape Its Innovation Strategy",
        "description": "",
        "summary": "On November 4, 2025, Pfizer reported third-quarter earnings showing a year-over-year decline in revenue to US$16.65 billion and net income to US$3.54 billion, while reaffirming full-year revenue guidance between US$61.0 billion and US$64.0 billion. The company's results reflect ongoing operational pressures, challenges related to COVID-19 product demand, and the impact of legal disputes over its bid for obesity drug developer Metsera. We'll explore how Pfizer's ongoing legal battle over the...",
        "pubDate": "2025-11-04T20:07:59Z",
        "displayTime": "2025-11-04T20:07:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizers-pfe-metsera-legal-fight-200759583.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizers-pfe-metsera-legal-fight-200759583.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T18:35:00+00:00",
    "headline": "Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera",
    "summary": "The Danish company’s latest offer is more than 30% about what Pfizer initially agreed to pay, not counting potential milestone payments.",
    "url": "https://www.barrons.com/articles/novo-nordisk-pfizer-metsera-stock-8b518c87?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "b3f95dd8-6a90-3c42-9d62-2297a803b146",
      "content": {
        "id": "b3f95dd8-6a90-3c42-9d62-2297a803b146",
        "contentType": "STORY",
        "title": "Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera",
        "description": "",
        "summary": "The Danish company’s latest offer is more than 30% about what Pfizer initially agreed to pay, not counting potential milestone payments.",
        "pubDate": "2025-11-04T18:35:00Z",
        "displayTime": "2025-11-04T18:35:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b3f95dd8-6a90-3c42-9d62-2297a803b146/novo-nordisk-is-still-beating.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/7c7e7a61ec051665904d4a2e8e8b85b4",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EpdNKn5yt9Ru67tPGMi5jw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/7c7e7a61ec051665904d4a2e8e8b85b4.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/efDMp3JVLH8i84fc3gR9sQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/7c7e7a61ec051665904d4a2e8e8b85b4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/novo-nordisk-pfizer-metsera-stock-8b518c87?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T18:11:00+00:00",
    "headline": "Pfizer Profit Falls Amid Lower Covid-19 Drug Demand",
    "summary": "Pfizer reported lower third-quarter profit as demand for its Covid-19 vaccine and antiviral drug continued to decline.",
    "url": "https://www.wsj.com/business/earnings/pfizer-profit-falls-amid-lower-covid-19-drug-demand-f3ab3ca1?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "f67ae4c6-3310-3072-b924-cb4ddd2d5b3e",
      "content": {
        "id": "f67ae4c6-3310-3072-b924-cb4ddd2d5b3e",
        "contentType": "STORY",
        "title": "Pfizer Profit Falls Amid Lower Covid-19 Drug Demand",
        "description": "",
        "summary": "Pfizer reported lower third-quarter profit as demand for its Covid-19 vaccine and antiviral drug continued to decline.",
        "pubDate": "2025-11-04T18:11:00Z",
        "displayTime": "2025-11-04T18:11:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f67ae4c6-3310-3072-b924-cb4ddd2d5b3e/pfizer-profit-falls-amid.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/be20148ea809196328d314b49a4329e0",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eG5nrKc34SqzFgQ1jYdQCg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/be20148ea809196328d314b49a4329e0.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oOorbaQ3x4PT22McoZg05g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/be20148ea809196328d314b49a4329e0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/business/earnings/pfizer-profit-falls-amid-lower-covid-19-drug-demand-f3ab3ca1?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T17:59:00+00:00",
    "headline": "Pfizer Stock Slips. Under the Surface, Earnings Weren’t Great.",
    "summary": "Pfizer  shares were lower on Tuesday despite third-quarter financial results that came in ahead of expectations.  Adjusted diluted earnings came in at $0.87 per share, well ahead of the $0.63 per share consensus estimate.  The stronger-than-expected revenue came from older products, while cost cuts and lower-than-expected tax liabilities helped the bottom line.",
    "url": "https://www.barrons.com/articles/pfizer-earnings-stock-price-b3e0f846?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "7246ffe5-2485-388a-8752-9173aaedd1a6",
      "content": {
        "id": "7246ffe5-2485-388a-8752-9173aaedd1a6",
        "contentType": "STORY",
        "title": "Pfizer Stock Slips. Under the Surface, Earnings Weren’t Great.",
        "description": "",
        "summary": "Pfizer  shares were lower on Tuesday despite third-quarter financial results that came in ahead of expectations.  Adjusted diluted earnings came in at $0.87 per share, well ahead of the $0.63 per share consensus estimate.  The stronger-than-expected revenue came from older products, while cost cuts and lower-than-expected tax liabilities helped the bottom line.",
        "pubDate": "2025-11-04T17:59:00Z",
        "displayTime": "2025-11-04T17:59:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7246ffe5-2485-388a-8752-9173aaedd1a6/pfizer-stock-slips-under-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/e79eb7dfaf2e2d22b9f8fc4c7613425c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8PiGpf4wc.D72W144T1Axw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/e79eb7dfaf2e2d22b9f8fc4c7613425c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q89MYulGiIu1k2xQkauN0g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/e79eb7dfaf2e2d22b9f8fc4c7613425c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/pfizer-earnings-stock-price-b3e0f846?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T16:59:46+00:00",
    "headline": "European Equities Close Mixed in Tuesday Trading; Novo Nordisk, Pfizer Battle Over Metsera Heats Up",
    "summary": "European stock markets closed mixed in Tuesday trading as the Stoxx Europe was down 0.30%, Germany's",
    "url": "https://finance.yahoo.com/news/european-equities-close-mixed-tuesday-165946857.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "1f0b0ddb-b7eb-3b7b-8dfc-4398ffddaf36",
      "content": {
        "id": "1f0b0ddb-b7eb-3b7b-8dfc-4398ffddaf36",
        "contentType": "STORY",
        "title": "European Equities Close Mixed in Tuesday Trading; Novo Nordisk, Pfizer Battle Over Metsera Heats Up",
        "description": "",
        "summary": "European stock markets closed mixed in Tuesday trading as the Stoxx Europe was down 0.30%, Germany's",
        "pubDate": "2025-11-04T16:59:46Z",
        "displayTime": "2025-11-04T16:59:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/european-equities-close-mixed-tuesday-165946857.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/european-equities-close-mixed-tuesday-165946857.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T16:45:23+00:00",
    "headline": "Top Midday Stories: Uber, Palantir Fall Despite Strong Earnings; Pfizer, Novo Nordisk Revise Offers for Metsera",
    "summary": "All three major US stock indexes were down in late-morning trading Tuesday, as concerns mount over v",
    "url": "https://finance.yahoo.com/news/top-midday-stories-uber-palantir-164523385.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "0160bc00-86ae-392d-9834-a4075a3dfa66",
      "content": {
        "id": "0160bc00-86ae-392d-9834-a4075a3dfa66",
        "contentType": "STORY",
        "title": "Top Midday Stories: Uber, Palantir Fall Despite Strong Earnings; Pfizer, Novo Nordisk Revise Offers for Metsera",
        "description": "",
        "summary": "All three major US stock indexes were down in late-morning trading Tuesday, as concerns mount over v",
        "pubDate": "2025-11-04T16:45:23Z",
        "displayTime": "2025-11-04T16:45:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-uber-palantir-164523385.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-uber-palantir-164523385.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T16:43:04+00:00",
    "headline": "‘Big Short’ investor Michael Burry follows up cryptic AI bubble warning with bearish stock activity on Nvidia and Palantir",
    "summary": "“Sometimes, we see bubbles,” Burry said in a recent X post. “Sometimes, there is something to do about it. Sometimes, the only winning move is not to play.”",
    "url": "https://finance.yahoo.com/news/big-short-investor-michael-burry-164304623.html",
    "source": "Fortune",
    "provider": "yfinance",
    "raw": {
      "id": "ad300edd-d41e-3605-bc10-55e0abc4fa37",
      "content": {
        "id": "ad300edd-d41e-3605-bc10-55e0abc4fa37",
        "contentType": "STORY",
        "title": "‘Big Short’ investor Michael Burry follows up cryptic AI bubble warning with bearish stock activity on Nvidia and Palantir",
        "description": "",
        "summary": "“Sometimes, we see bubbles,” Burry said in a recent X post. “Sometimes, there is something to do about it. Sometimes, the only winning move is not to play.”",
        "pubDate": "2025-11-04T16:43:04Z",
        "displayTime": "2025-11-04T16:43:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/fortune_175/23814d805c1af4355f14ff438465f20f",
          "originalWidth": 2048,
          "originalHeight": 1393,
          "caption": "Investor Michael Burry appears to be bearish on some AI giants and has cryptically warned of a bubble.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ic6aMIe0uE4s.DpEBiwcgg--~B/aD0xMzkzO3c9MjA0ODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/fortune_175/23814d805c1af4355f14ff438465f20f.cf.webp",
              "width": 2048,
              "height": 1393,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FZAp7p9TK9opl8_JwJMqUg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fortune_175/23814d805c1af4355f14ff438465f20f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Fortune",
          "url": "http://fortune.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/big-short-investor-michael-burry-164304623.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/big-short-investor-michael-burry-164304623.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "HAL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T16:25:15+00:00",
    "headline": "Pfizer (PFE) Q3 2025 Earnings Call Transcript",
    "summary": "Albert Bourla: The past few months have been pivotal for Pfizer Inc. We are really excited about our future and confident that we are in a strong position to continue delivering value for patients and our shareholders.  What I can say, is that our belief in the promise of the Pfizer Inc. and MedCera combination is strong, and unwavering, We are confident it will create substantial value for shareholders and advance innovation to bring important medicines to patients in the high-growth therapeutic area of obesity.",
    "url": "https://www.fool.com/earnings/call-transcripts/2025/11/04/pfizer-pfe-q3-2025-earnings-call-transcript/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "d2bb6235-a2a2-3513-9d7e-20df70693962",
      "content": {
        "id": "d2bb6235-a2a2-3513-9d7e-20df70693962",
        "contentType": "STORY",
        "title": "Pfizer (PFE) Q3 2025 Earnings Call Transcript",
        "description": "",
        "summary": "Albert Bourla: The past few months have been pivotal for Pfizer Inc. We are really excited about our future and confident that we are in a strong position to continue delivering value for patients and our shareholders.  What I can say, is that our belief in the promise of the Pfizer Inc. and MedCera combination is strong, and unwavering, We are confident it will create substantial value for shareholders and advance innovation to bring important medicines to patients in the high-growth therapeutic area of obesity.",
        "pubDate": "2025-11-04T16:25:15Z",
        "displayTime": "2025-11-04T16:25:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73",
          "originalWidth": 400,
          "originalHeight": 427,
          "caption": "Logo of jester cap with thought bubble.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V1aMxfEJkXDsPjicitZiIw--~B/aD00Mjc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 400,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XzH.opsl71yJif6AsJGwPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e48e86dda35543079ee2080fd9208b73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/earnings/call-transcripts/2025/11/04/pfizer-pfe-q3-2025-earnings-call-transcript/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-q3-2025-earnings-162515236.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T16:18:00+00:00",
    "headline": "Earnings Data Deluge",
    "summary": "Earnings Data Deluge",
    "url": "https://finance.yahoo.com/news/earnings-data-deluge-161800514.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "21de8ddf-8c08-3e89-9292-1a08358cc5a7",
      "content": {
        "id": "21de8ddf-8c08-3e89-9292-1a08358cc5a7",
        "contentType": "STORY",
        "title": "Earnings Data Deluge",
        "description": "",
        "summary": "Earnings Data Deluge",
        "pubDate": "2025-11-04T16:18:00Z",
        "displayTime": "2025-11-04T16:18:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YqcOBKMNrThKvJSga1KIbw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Vj9Bix098SQE5mY9G0P2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/earnings-data-deluge-161800514.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/earnings-data-deluge-161800514.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "BP"
            },
            {
              "symbol": "BPAQF"
            },
            {
              "symbol": "ADM"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T16:15:00+00:00",
    "headline": "Pfizer Q3 Earnings Beat Estimates, Sales Decline as COVID Demand Cools",
    "summary": "Pfizer posts Q3 earnings beat and raises EPS guidance, but weaker COVID product sales weigh on overall revenue momentum.",
    "url": "https://finance.yahoo.com/news/pfizer-q3-earnings-beat-estimates-161500387.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "aca27d54-fc99-315b-ad71-4c355588f13e",
      "content": {
        "id": "aca27d54-fc99-315b-ad71-4c355588f13e",
        "contentType": "STORY",
        "title": "Pfizer Q3 Earnings Beat Estimates, Sales Decline as COVID Demand Cools",
        "description": "",
        "summary": "Pfizer posts Q3 earnings beat and raises EPS guidance, but weaker COVID product sales weigh on overall revenue momentum.",
        "pubDate": "2025-11-04T16:15:00Z",
        "displayTime": "2025-11-04T16:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YqcOBKMNrThKvJSga1KIbw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Vj9Bix098SQE5mY9G0P2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1e2f63f10f05b0390ba8b63bd4ef031c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-q3-earnings-beat-estimates-161500387.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-q3-earnings-beat-estimates-161500387.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "1530.HK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T15:54:29+00:00",
    "headline": "Pfizer’s Q3 Earnings Beat on Top and Bottom Lines",
    "summary": "Pfizer (NYSE: PFE) beat earnings expectations decisively this morning, posting adjusted EPS of $0.87 against a $0.64 consensus and revenue of $16.65 billion versus $16.50 billion expected. The stock gapped up roughly 12.6% in pre-market trading, reflecting strong investor validation of both the beat and the company’s reaffirmed full-year guidance paired with a raised EPS ... Pfizer’s Q3 Earnings Beat on Top and Bottom Lines",
    "url": "https://247wallst.com/investing/2025/11/04/pfizers-q3-earnings-beat-on-top-and-bottom-lines/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "0235040f-9285-314b-95f9-e5e94abf5d7a",
      "content": {
        "id": "0235040f-9285-314b-95f9-e5e94abf5d7a",
        "contentType": "STORY",
        "title": "Pfizer’s Q3 Earnings Beat on Top and Bottom Lines",
        "description": "",
        "summary": "Pfizer (NYSE: PFE) beat earnings expectations decisively this morning, posting adjusted EPS of $0.87 against a $0.64 consensus and revenue of $16.65 billion versus $16.50 billion expected. The stock gapped up roughly 12.6% in pre-market trading, reflecting strong investor validation of both the beat and the company’s reaffirmed full-year guidance paired with a raised EPS ... Pfizer’s Q3 Earnings Beat on Top and Bottom Lines",
        "pubDate": "2025-11-04T15:54:29Z",
        "displayTime": "2025-11-04T15:54:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/b070b67b4a9bf7920b9729a12abbf286",
          "originalWidth": 1367,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y_zz88giH70GIpRBvJPTvw--~B/aD03Njg7dz0xMzY3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/b070b67b4a9bf7920b9729a12abbf286.cf.webp",
              "width": 1367,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1j1fAyZs1HPpy6fzz9LPdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/b070b67b4a9bf7920b9729a12abbf286.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/11/04/pfizers-q3-earnings-beat-on-top-and-bottom-lines/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-q3-earnings-beat-top-155429450.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T15:44:04+00:00",
    "headline": "Update: Metsera Gets 'Superior' Acquisition Bid From Novo Nordisk, Challenging Pfizer Merger",
    "summary": "(Updates with additional details starting in second paragraph.) Metsera (MTSR) said Tuesday its b",
    "url": "https://finance.yahoo.com/news/metsera-gets-apos-superior-apos-154404386.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "77c31e9e-c110-3c15-8e54-bea1da8ed21a",
      "content": {
        "id": "77c31e9e-c110-3c15-8e54-bea1da8ed21a",
        "contentType": "STORY",
        "title": "Update: Metsera Gets 'Superior' Acquisition Bid From Novo Nordisk, Challenging Pfizer Merger",
        "description": "",
        "summary": "(Updates with additional details starting in second paragraph.) Metsera (MTSR) said Tuesday its b",
        "pubDate": "2025-11-04T15:44:04Z",
        "displayTime": "2025-11-04T15:44:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/metsera-gets-apos-superior-apos-154404386.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/metsera-gets-apos-superior-apos-154404386.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T15:38:24+00:00",
    "headline": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer and acquire the development-stage drugmaker Metsera.  Novo is now offering to pay as much as $10 billion for the company, Metsera said Tuesday.  Pfizer also has altered the offer it made in September of nearly $4.9 billion to provide more cash up front, Metsera said.",
    "url": "https://finance.yahoo.com/news/novo-nordisk-hikes-metsera-bid-153824830.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "5aa2bdfa-228d-3483-9909-a533b4a035f7",
      "content": {
        "id": "5aa2bdfa-228d-3483-9909-a533b4a035f7",
        "contentType": "STORY",
        "title": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer and acquire the development-stage drugmaker Metsera.  Novo is now offering to pay as much as $10 billion for the company, Metsera said Tuesday.  Pfizer also has altered the offer it made in September of nearly $4.9 billion to provide more cash up front, Metsera said.",
        "pubDate": "2025-11-04T15:38:24Z",
        "displayTime": "2025-11-04T15:38:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ap_finance_articles_694/40ec4e41568abda178c65538c0f37b71",
          "originalWidth": 8640,
          "originalHeight": 5760,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZ9xzXz9ZNRunWmPVBmD9Q--~B/aD01NzYwO3c9ODY0MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/ap_finance_articles_694/40ec4e41568abda178c65538c0f37b71.cf.webp",
              "width": 8640,
              "height": 5760,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LqY8WYHWWVjjxF4Jo1kDtA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ap_finance_articles_694/40ec4e41568abda178c65538c0f37b71.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-hikes-metsera-bid-153824830.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-hikes-metsera-bid-153824830.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T15:35:00+00:00",
    "headline": "Pre-markets Sell Off on No New Economic News",
    "summary": "This morning was to bring us new U.S. Trade Deficit figures, Factory Orders and JOLTS, but due to the government shutdown are not out.",
    "url": "https://finance.yahoo.com/news/pre-markets-sell-off-no-153500530.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e83b7e60-0875-3b26-b18c-0b7e737173a2",
      "content": {
        "id": "e83b7e60-0875-3b26-b18c-0b7e737173a2",
        "contentType": "STORY",
        "title": "Pre-markets Sell Off on No New Economic News",
        "description": "",
        "summary": "This morning was to bring us new U.S. Trade Deficit figures, Factory Orders and JOLTS, but due to the government shutdown are not out.",
        "pubDate": "2025-11-04T15:35:00Z",
        "displayTime": "2025-11-04T15:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pre-markets-sell-off-no-153500530.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pre-markets-sell-off-no-153500530.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "BP"
            },
            {
              "symbol": "BPAQF"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "SPOT"
            },
            {
              "symbol": "ADM"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T15:22:21+00:00",
    "headline": "Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle",
    "summary": "Pfizer Inc. and Novo Nordisk A/S boosted their bids for obesity startup Metsera Inc. Novo's updated offer values Metsera at a total of $10 billion, compared to the offer from Pfizer, which values the company at about $8.1 billion. Madison Muller reports on Bloomberg Television.",
    "url": "https://finance.yahoo.com/video/novo-pfizer-boost-metsera-bids-152221812.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "0d2c30de-5075-381c-a039-2fe76f8d6c8c",
      "content": {
        "id": "0d2c30de-5075-381c-a039-2fe76f8d6c8c",
        "contentType": "VIDEO",
        "title": "Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle",
        "description": "Pfizer Inc. and Novo Nordisk A/S boosted their bids for obesity startup Metsera Inc. Novo's updated offer values Metsera at a total of $10 billion, compared to the offer from Pfizer, which values the company at about $8.1 billion. Madison Muller reports on Bloomberg Television.",
        "summary": "Pfizer Inc. and Novo Nordisk A/S boosted their bids for obesity startup Metsera Inc. Novo's updated offer values Metsera at a total of $10 billion, compared to the offer from Pfizer, which values the company at about $8.1 billion. Madison Muller reports on Bloomberg Television.",
        "pubDate": "2025-11-04T15:22:21Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_markets_video_2/d438c656011dbf9be67bc8f66eff0ae3",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.LSWnymyyMnquatXfF871g--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_video_2/d438c656011dbf9be67bc8f66eff0ae3.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0z3baqsAfGLPEWijvADIPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_markets_video_2/d438c656011dbf9be67bc8f66eff0ae3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/novo-pfizer-boost-metsera-bids-152221812.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/novo-pfizer-boost-metsera-bids-152221812.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T15:05:00+00:00",
    "headline": "Burry Reveals Nvidia and Palantir Puts After Bubble Warning",
    "summary": "Burry, who rose to fame for his 2008 bet against the US housing market, bought put options — that profit from price declines — on Nvidia and Palantir, according to 13F regulatory filings released on Monday.  It’s unclear if the reported positions are outright or part of spread trades, where one option is bought and another sold.",
    "url": "https://finance.yahoo.com/news/burry-discloses-puts-nvidia-palantir-120001463.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "36aa7cb4-22fc-3130-a49d-82195cc2ea2e",
      "content": {
        "id": "36aa7cb4-22fc-3130-a49d-82195cc2ea2e",
        "contentType": "STORY",
        "title": "Burry Reveals Nvidia and Palantir Puts After Bubble Warning",
        "description": "",
        "summary": "Burry, who rose to fame for his 2008 bet against the US housing market, bought put options — that profit from price declines — on Nvidia and Palantir, according to 13F regulatory filings released on Monday.  It’s unclear if the reported positions are outright or part of spread trades, where one option is bought and another sold.",
        "pubDate": "2025-11-04T15:05:00Z",
        "displayTime": "2025-11-04T15:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/d1f881299def975cdb17326702b0292c",
          "originalWidth": 2000,
          "originalHeight": 1334,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cRi5jYjbJ3w0NyGiat5iEw--~B/aD0xMzM0O3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_holding_pen_162/d1f881299def975cdb17326702b0292c.cf.webp",
              "width": 2000,
              "height": 1334,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RZKHCrkB9nZDoo5922wwxw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/d1f881299def975cdb17326702b0292c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/burry-discloses-puts-nvidia-palantir-120001463.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/burry-discloses-puts-nvidia-palantir-120001463.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "HAL"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T15:00:02+00:00",
    "headline": "Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings",
    "summary": "While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://finance.yahoo.com/news/heres-key-metrics-tell-us-150002598.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "cfffe6e3-6ac0-39cd-9a20-68c336b49119",
      "content": {
        "id": "cfffe6e3-6ac0-39cd-9a20-68c336b49119",
        "contentType": "STORY",
        "title": "Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings",
        "description": "",
        "summary": "While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
        "pubDate": "2025-11-04T15:00:02Z",
        "displayTime": "2025-11-04T15:00:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9",
          "originalWidth": 1000,
          "originalHeight": 603,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YgRrCYuBdR1wa08RtjoPHQ--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9.cf.webp",
              "width": 1000,
              "height": 603,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jAWLk_UfDMDSToA2irhEEg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-key-metrics-tell-us-150002598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-key-metrics-tell-us-150002598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:45:03+00:00",
    "headline": "Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows",
    "summary": "The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.  Approval of updated shots also came several weeks later than usual, and Pfizer said Tuesday that hurt sales as well.  The Centers for Disease Control and Prevention last month stopped recommending COVID-19 shots for anyone, instead leaving the choice up to patients.",
    "url": "https://finance.yahoo.com/news/pfizer-covid-19-vaccine-sales-144503791.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "6714d653-afef-300c-a5fe-7dfe0e404288",
      "content": {
        "id": "6714d653-afef-300c-a5fe-7dfe0e404288",
        "contentType": "STORY",
        "title": "Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows",
        "description": "",
        "summary": "The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.  Approval of updated shots also came several weeks later than usual, and Pfizer said Tuesday that hurt sales as well.  The Centers for Disease Control and Prevention last month stopped recommending COVID-19 shots for anyone, instead leaving the choice up to patients.",
        "pubDate": "2025-11-04T14:45:03Z",
        "displayTime": "2025-11-04T14:45:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ap_finance_articles_694/ad821e609cd67b2ba80398b482edf535",
          "originalWidth": 6714,
          "originalHeight": 4404,
          "caption": "FILE - A healthcare worker prepares a shot of the Pfizer COVID-19 vaccine in La Paz, Bolivia, Jan. 7, 2025. (AP Photo/Juan Karita, File)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/149SLPpavASrnpfRvNXKRA--~B/aD00NDA0O3c9NjcxNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/ap_finance_articles_694/ad821e609cd67b2ba80398b482edf535.cf.webp",
              "width": 6714,
              "height": 4404,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ggpoa60OXlxGyGElPcbNpw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ap_finance_articles_694/ad821e609cd67b2ba80398b482edf535.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-covid-19-vaccine-sales-144503791.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-covid-19-vaccine-sales-144503791.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:45:00+00:00",
    "headline": "Hyperlipidemia Drugs Market Report 2025: $24.74 Industry Led by Pfizer, Merck & AbbVie, With Asia-Pacific Poised for Strong Growth Amid Trade-Driven Supply Chain Shifts - Global Forecast to 2034",
    "summary": "The hyperlipidemia drugs market is growing due to rising cardiovascular disease prevalence, increasing cholesterol management awareness, and aging populations. Opportunities lie in personalized and combination therapies, digital health integration, non-statin alternatives, and expanding markets in Asia-Pacific. Hyperlipidemia Drugs Market Hyperlipidemia Drugs Market Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The \"Hyperlipidemia Drugs Market Report 2025\" has been added to ResearchAndMarkets.com's",
    "url": "https://finance.yahoo.com/news/hyperlipidemia-drugs-market-report-2025-144500707.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "f41e9d02-8bb2-303f-9592-b12855a5de45",
      "content": {
        "id": "f41e9d02-8bb2-303f-9592-b12855a5de45",
        "contentType": "STORY",
        "title": "Hyperlipidemia Drugs Market Report 2025: $24.74 Industry Led by Pfizer, Merck & AbbVie, With Asia-Pacific Poised for Strong Growth Amid Trade-Driven Supply Chain Shifts - Global Forecast to 2034",
        "description": "",
        "summary": "The hyperlipidemia drugs market is growing due to rising cardiovascular disease prevalence, increasing cholesterol management awareness, and aging populations. Opportunities lie in personalized and combination therapies, digital health integration, non-statin alternatives, and expanding markets in Asia-Pacific. Hyperlipidemia Drugs Market Hyperlipidemia Drugs Market Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The \"Hyperlipidemia Drugs Market Report 2025\" has been added to ResearchAndMarkets.com's",
        "pubDate": "2025-11-04T14:45:00Z",
        "displayTime": "2025-11-04T14:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/37f2ba6c1987ec3f95b7a9adda21e40a",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Hyperlipidemia Drugs Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d2nqQKPmXf_Z3gH4o_2k0A--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/37f2ba6c1987ec3f95b7a9adda21e40a.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wpVxz2GEI4O42YruP8xaFA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/37f2ba6c1987ec3f95b7a9adda21e40a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hyperlipidemia-drugs-market-report-2025-144500707.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hyperlipidemia-drugs-market-report-2025-144500707.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:31:00+00:00",
    "headline": "Novo Nordisk submits updated proposal to acquire Metsera, Inc.",
    "summary": "Bagsværd, Denmark, 4 November 2025 – On 30 October 2025, Novo Nordisk announced the submission of an unsolicited proposal to acquire Metsera, Inc. (Metsera)1. Today, Novo Nordisk confirms that it has submitted an updated, unsolicited proposal to acquire Metsera. The updated proposal has been declared superior by Metsera’s board of directors. The acquisition of Metsera, including its early and development-stage incretin and non-incretin analogue peptide programmes, would provide Novo Nordisk the",
    "url": "https://finance.yahoo.com/news/novo-nordisk-submits-updated-proposal-143100724.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "2a2a58ff-6a51-304e-b56c-9d9e2f4ce975",
      "content": {
        "id": "2a2a58ff-6a51-304e-b56c-9d9e2f4ce975",
        "contentType": "STORY",
        "title": "Novo Nordisk submits updated proposal to acquire Metsera, Inc.",
        "description": "",
        "summary": "Bagsværd, Denmark, 4 November 2025 – On 30 October 2025, Novo Nordisk announced the submission of an unsolicited proposal to acquire Metsera, Inc. (Metsera)1. Today, Novo Nordisk confirms that it has submitted an updated, unsolicited proposal to acquire Metsera. The updated proposal has been declared superior by Metsera’s board of directors. The acquisition of Metsera, including its early and development-stage incretin and non-incretin analogue peptide programmes, would provide Novo Nordisk the",
        "pubDate": "2025-11-04T14:31:00Z",
        "displayTime": "2025-11-04T14:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/390a90dca9ab1da0d2c89c641db85b9e",
          "originalWidth": 600,
          "originalHeight": 427,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cBWaijHhCwTpKXQaX3aOwQ--~B/aD00Mjc7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/390a90dca9ab1da0d2c89c641db85b9e.cf.webp",
              "width": 600,
              "height": 427,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KUVppJinUZmSka5dRXSyuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/390a90dca9ab1da0d2c89c641db85b9e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-submits-updated-proposal-143100724.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-submits-updated-proposal-143100724.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "META"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:30:00+00:00",
    "headline": "/C O R R E C T I O N -- Metsera, Inc./",
    "summary": "Metsera, Inc. (NASDAQ: MTSR) (\"Metsera\") today announced that its Board of Directors had determined, after consultation with its outside counsel and financial advisors, that a revised proposal that Metsera received from Novo Nordisk A/S (Nasdaq Copenhagen: NOVO B) (\"Novo Nordisk\") to acquire Metsera (the \"Novo Nordisk Amended Proposal\") constitutes a \"Superior Company Proposal\" as defined in Metsera's existing Merger Agreement with Pfizer (the \"Pfizer Merger Agreement\").",
    "url": "https://finance.yahoo.com/news/metsera-receives-amended-proposal-novo-140900582.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "89d512a8-28d6-3ffd-88b3-862ed3b64634",
      "content": {
        "id": "89d512a8-28d6-3ffd-88b3-862ed3b64634",
        "contentType": "STORY",
        "title": "/C O R R E C T I O N -- Metsera, Inc./",
        "description": "",
        "summary": "Metsera, Inc. (NASDAQ: MTSR) (\"Metsera\") today announced that its Board of Directors had determined, after consultation with its outside counsel and financial advisors, that a revised proposal that Metsera received from Novo Nordisk A/S (Nasdaq Copenhagen: NOVO B) (\"Novo Nordisk\") to acquire Metsera (the \"Novo Nordisk Amended Proposal\") constitutes a \"Superior Company Proposal\" as defined in Metsera's existing Merger Agreement with Pfizer (the \"Pfizer Merger Agreement\").",
        "pubDate": "2025-11-04T14:30:00Z",
        "displayTime": "2025-11-04T14:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f2b5379519824664c81a7d8ceb543bcc",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/waHJla4.Ktc86On_yONNAg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/f2b5379519824664c81a7d8ceb543bcc.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6dq7q3N424i1xriTla8.TA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f2b5379519824664c81a7d8ceb543bcc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/metsera-receives-amended-proposal-novo-140900582.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/metsera-receives-amended-proposal-novo-140900582.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:17:09+00:00",
    "headline": "Pfizer (PFE): Is There Untapped Value in Today’s Evolving Pharmaceutical Market?",
    "summary": "Pfizer (PFE) shares have seen some moderate movement lately, offering investors a chance to reconsider the company’s valuation as the pharmaceutical landscape evolves. Despite a challenging month for the stock, some metrics suggest there could be opportunities ahead. See our latest analysis for Pfizer. Pfizer’s share price has been on a bumpy ride, falling nearly 10% over the last month and down 7% so far this year. Even so, the 12-month total shareholder return of -4.9% shows recent weakness...",
    "url": "https://finance.yahoo.com/news/pfizer-pfe-untapped-value-today-141709544.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "bda76aba-178d-30f2-b2ee-daa8e0b36979",
      "content": {
        "id": "bda76aba-178d-30f2-b2ee-daa8e0b36979",
        "contentType": "STORY",
        "title": "Pfizer (PFE): Is There Untapped Value in Today’s Evolving Pharmaceutical Market?",
        "description": "",
        "summary": "Pfizer (PFE) shares have seen some moderate movement lately, offering investors a chance to reconsider the company’s valuation as the pharmaceutical landscape evolves. Despite a challenging month for the stock, some metrics suggest there could be opportunities ahead. See our latest analysis for Pfizer. Pfizer’s share price has been on a bumpy ride, falling nearly 10% over the last month and down 7% so far this year. Even so, the 12-month total shareholder return of -4.9% shows recent weakness...",
        "pubDate": "2025-11-04T14:17:09Z",
        "displayTime": "2025-11-04T14:17:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-untapped-value-today-141709544.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-untapped-value-today-141709544.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:01:36+00:00",
    "headline": "Pfizer Lifts Full-Year Earnings Outlook as Third-Quarter Results Top Street Views",
    "summary": "Pfizer (PFE) raised its full-year earnings outlook on Tuesday and reported better-than-expected thir",
    "url": "https://finance.yahoo.com/news/pfizer-lifts-full-earnings-outlook-140136392.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "777eaebf-209e-3535-b6ac-62301ceff676",
      "content": {
        "id": "777eaebf-209e-3535-b6ac-62301ceff676",
        "contentType": "STORY",
        "title": "Pfizer Lifts Full-Year Earnings Outlook as Third-Quarter Results Top Street Views",
        "description": "",
        "summary": "Pfizer (PFE) raised its full-year earnings outlook on Tuesday and reported better-than-expected thir",
        "pubDate": "2025-11-04T14:01:36Z",
        "displayTime": "2025-11-04T14:01:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/57da8883bfabdae77ebf3538f9a9c65e",
          "originalWidth": 1024,
          "originalHeight": 678,
          "caption": "Pfizer PFE.jpg - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YNLqneDuTzpo0zS49qPy1w--~B/aD02Nzg7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/57da8883bfabdae77ebf3538f9a9c65e.cf.webp",
              "width": 1024,
              "height": 678,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3kXb4gkUeDehf9SrFuQJWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/57da8883bfabdae77ebf3538f9a9c65e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-lifts-full-earnings-outlook-140136392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-lifts-full-earnings-outlook-140136392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T13:39:05+00:00",
    "headline": "Pfizer’s (NYSE:PFE) Q3 Earnings Results: Revenue In Line With Expectations",
    "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.87 per share was 37% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/pfizer-nyse-pfe-q3-earnings-133905283.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "79bcbf7c-7d94-3ffe-8108-df7e19d73586",
      "content": {
        "id": "79bcbf7c-7d94-3ffe-8108-df7e19d73586",
        "contentType": "STORY",
        "title": "Pfizer’s (NYSE:PFE) Q3 Earnings Results: Revenue In Line With Expectations",
        "description": "",
        "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.87 per share was 37% above analysts’ consensus estimates.",
        "pubDate": "2025-11-04T13:39:05Z",
        "displayTime": "2025-11-04T13:39:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "PFE Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o3tZoPUio75qXATbHoc_Hg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o5rZqD7vIoFGnsFYAS_Ztw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-nyse-pfe-q3-earnings-133905283.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-nyse-pfe-q3-earnings-133905283.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T13:36:00+00:00",
    "headline": "Should You Buy Moderna Stock Ahead of Q3 Earnings Report?",
    "summary": "MRNA is likely to have faced earnings pressure and pipeline setbacks as waning COVID-19 vaccine demand weighs on its outlook.",
    "url": "https://finance.yahoo.com/news/buy-moderna-stock-ahead-q3-133600619.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "82ac8a18-39f2-35dc-afbd-e7e7492708e2",
      "content": {
        "id": "82ac8a18-39f2-35dc-afbd-e7e7492708e2",
        "contentType": "STORY",
        "title": "Should You Buy Moderna Stock Ahead of Q3 Earnings Report?",
        "description": "",
        "summary": "MRNA is likely to have faced earnings pressure and pipeline setbacks as waning COVID-19 vaccine demand weighs on its outlook.",
        "pubDate": "2025-11-04T13:36:00Z",
        "displayTime": "2025-11-04T13:36:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RbEQ9ffI_C.cs8maxLm5aA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7WrOhRUUvHYeo9ae0mpZAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-moderna-stock-ahead-q3-133600619.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-moderna-stock-ahead-q3-133600619.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T13:17:53+00:00",
    "headline": "Michael Burry buys puts on Nvidia, Palantir",
    "summary": "Investing.com -- Michael Burry’s Scion Asset Management has placed bearish bets on Nvidia Corp. and Palantir Technologies Inc. in Q3, according to regulatory filings released Monday.",
    "url": "https://finance.yahoo.com/news/michael-burry-buys-puts-nvidia-131753320.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "99d899bf-63f3-386a-a64a-23cac16ad4e4",
      "content": {
        "id": "99d899bf-63f3-386a-a64a-23cac16ad4e4",
        "contentType": "STORY",
        "title": "Michael Burry buys puts on Nvidia, Palantir",
        "description": "",
        "summary": "Investing.com -- Michael Burry’s Scion Asset Management has placed bearish bets on Nvidia Corp. and Palantir Technologies Inc. in Q3, according to regulatory filings released Monday.",
        "pubDate": "2025-11-04T13:17:53Z",
        "displayTime": "2025-11-04T13:17:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/michael-burry-buys-puts-nvidia-131753320.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/michael-burry-buys-puts-nvidia-131753320.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "HAL"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T13:06:09+00:00",
    "headline": "Pfizer files second lawsuit against Metsera, Novo Nordisk",
    "summary": "Pfizer (PFE) announced that it has filed a second lawsuit against Metsera, its controlling stockholders, and Novo Nordisk (NVO) in the United States District Court for the District of Delaware. The lawsuit asserts that Novo Nordisk’s recent proposal to acquire Metsera constitutes an anticompetitive action by Novo Nordisk to protect its dominant market position in GLP-1s by capturing and killing a nascent American competitor before it gains the support of Pfizer. The lawsuit alleges that Novo Nor",
    "url": "https://finance.yahoo.com/news/pfizer-files-second-lawsuit-against-130609758.html",
    "source": "TipRanks",
    "provider": "yfinance",
    "raw": {
      "id": "555f9208-192a-3fd8-8210-11d5791ef88e",
      "content": {
        "id": "555f9208-192a-3fd8-8210-11d5791ef88e",
        "contentType": "STORY",
        "title": "Pfizer files second lawsuit against Metsera, Novo Nordisk",
        "description": "",
        "summary": "Pfizer (PFE) announced that it has filed a second lawsuit against Metsera, its controlling stockholders, and Novo Nordisk (NVO) in the United States District Court for the District of Delaware. The lawsuit asserts that Novo Nordisk’s recent proposal to acquire Metsera constitutes an anticompetitive action by Novo Nordisk to protect its dominant market position in GLP-1s by capturing and killing a nascent American competitor before it gains the support of Pfizer. The lawsuit alleges that Novo Nor",
        "pubDate": "2025-11-04T13:06:09Z",
        "displayTime": "2025-11-04T13:06:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/tipranks_452/060c7819ab2e6aac03de78d24e089052",
          "originalWidth": 192,
          "originalHeight": 192,
          "caption": "https://www.tipranks.com/news/the-fly/pfizer-files-second-lawsuit-against-metsera-novo-nordisk-thefly",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vZK3M5BXOPYNoopjKe3ucA--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/060c7819ab2e6aac03de78d24e089052.cf.webp",
              "width": 192,
              "height": 192,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KMXErhC4t58oQ8xCJHHKJg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/060c7819ab2e6aac03de78d24e089052.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TipRanks",
          "url": "https://www.tipranks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-files-second-lawsuit-against-130609758.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-files-second-lawsuit-against-130609758.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T13:00:03+00:00",
    "headline": "Pfizer (PFE) Surpasses Q3 Earnings and Revenue Estimates",
    "summary": "Pfizer (PFE) delivered earnings and revenue surprises of +31.82% and +0.30%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/pfizer-pfe-surpasses-q3-earnings-130003852.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "79c4a0cb-707b-3177-88bd-1400d1891a2a",
      "content": {
        "id": "79c4a0cb-707b-3177-88bd-1400d1891a2a",
        "contentType": "STORY",
        "title": "Pfizer (PFE) Surpasses Q3 Earnings and Revenue Estimates",
        "description": "",
        "summary": "Pfizer (PFE) delivered earnings and revenue surprises of +31.82% and +0.30%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2025-11-04T13:00:03Z",
        "displayTime": "2025-11-04T13:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c",
          "originalWidth": 900,
          "originalHeight": 675,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5VYVrk.dAWOtAbYePjBVnw--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c.cf.webp",
              "width": 900,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bx6KQdkgJ6y2nL6XqljE4w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-surpasses-q3-earnings-130003852.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-surpasses-q3-earnings-130003852.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T12:45:00+00:00",
    "headline": "Is Eli Lilly a Millionaire Maker?",
    "summary": "Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider.",
    "url": "https://www.fool.com/investing/2025/11/04/is-eli-lilly-a-millionaire-maker/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "27ccbfae-7962-330f-85b9-ef1a7cbd2a43",
      "content": {
        "id": "27ccbfae-7962-330f-85b9-ef1a7cbd2a43",
        "contentType": "STORY",
        "title": "Is Eli Lilly a Millionaire Maker?",
        "description": "",
        "summary": "Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider.",
        "pubDate": "2025-11-04T12:45:00Z",
        "displayTime": "2025-11-04T12:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/271a6a79649854b7fc2e8c888b406d38",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "A person using an injection pen.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TRXT7qBYAd0bm0zLjEApsQ--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/271a6a79649854b7fc2e8c888b406d38.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ukwx7zHvTle87Vv7MYCkOQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/271a6a79649854b7fc2e8c888b406d38.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/04/is-eli-lilly-a-millionaire-maker/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-millionaire-maker-124500168.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T12:35:28+00:00",
    "headline": "Pfizer's $4.9 Billion Gamble: Inside Its Legal War to Reclaim the Obesity Market",
    "summary": "After raising its 2025 profit forecast again, Pfizer turns its sights on Novo Nordisk in a billion-dollar obesity drug showdown.",
    "url": "https://finance.yahoo.com/news/pfizers-4-9-billion-gamble-123528310.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "0e765dc9-3952-39e5-8d0c-5b1c19f0c4d0",
      "content": {
        "id": "0e765dc9-3952-39e5-8d0c-5b1c19f0c4d0",
        "contentType": "STORY",
        "title": "Pfizer's $4.9 Billion Gamble: Inside Its Legal War to Reclaim the Obesity Market",
        "description": "",
        "summary": "After raising its 2025 profit forecast again, Pfizer turns its sights on Novo Nordisk in a billion-dollar obesity drug showdown.",
        "pubDate": "2025-11-04T12:35:28Z",
        "displayTime": "2025-11-04T12:35:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vu.kxzmN7yCA.wz8Cs.cHg--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Brb0J12XOUXl4lathAg3vw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/08081c8c254eb269c81ba8feeb03a4b4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizers-4-9-billion-gamble-123528310.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizers-4-9-billion-gamble-123528310.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T12:20:53+00:00",
    "headline": "Pfizer raises and narrows full-year earnings guidance",
    "summary": "Investing.com - Pfizer has raised and narrowed its full-year earnings outlook for a second consecutive quarter, after strong demand for its blood thinner medication helped fuel solid third-quarter returns.",
    "url": "https://finance.yahoo.com/news/pfizer-raises-narrows-full-earnings-122053788.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "4e9fbdb4-4162-3505-a8fd-c3fe9a823e83",
      "content": {
        "id": "4e9fbdb4-4162-3505-a8fd-c3fe9a823e83",
        "contentType": "STORY",
        "title": "Pfizer raises and narrows full-year earnings guidance",
        "description": "",
        "summary": "Investing.com - Pfizer has raised and narrowed its full-year earnings outlook for a second consecutive quarter, after strong demand for its blood thinner medication helped fuel solid third-quarter returns.",
        "pubDate": "2025-11-04T12:20:53Z",
        "displayTime": "2025-11-04T12:20:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-raises-narrows-full-earnings-122053788.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-raises-narrows-full-earnings-122053788.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T12:16:40+00:00",
    "headline": "Stocks Down Pre-Bell Ahead of Latest Round of Corporate Earnings",
    "summary": "US equity futures were trending lower on Tuesday as traders await the latest batch of corporate earn",
    "url": "https://finance.yahoo.com/news/stocks-down-pre-bell-ahead-121640163.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "c22316a8-ee1c-360d-9a1c-6e4b9693f119",
      "content": {
        "id": "c22316a8-ee1c-360d-9a1c-6e4b9693f119",
        "contentType": "STORY",
        "title": "Stocks Down Pre-Bell Ahead of Latest Round of Corporate Earnings",
        "description": "",
        "summary": "US equity futures were trending lower on Tuesday as traders await the latest batch of corporate earn",
        "pubDate": "2025-11-04T12:16:40Z",
        "displayTime": "2025-11-04T12:16:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/97f8529991dafd96c1cb04f4325c2221",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "stock board prices market trading equities wall street - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/87XBhEt7CFHMBVoSXYEyuA--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/97f8529991dafd96c1cb04f4325c2221.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3xyDW5YnhBbRlncnrYHIuw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/97f8529991dafd96c1cb04f4325c2221.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/stocks-down-pre-bell-ahead-121640163.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stocks-down-pre-bell-ahead-121640163.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "SMCI"
            },
            {
              "symbol": "RIVN"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NCLH"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "ANET"
            },
            {
              "symbol": "GPN"
            },
            {
              "symbol": "MAR"
            },
            {
              "symbol": "YUM"
            },
            {
              "symbol": "ADM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T12:03:37+00:00",
    "headline": "Pfizer: Q3 Earnings Snapshot",
    "summary": "NEW YORK (AP) — Pfizer Inc. PFE) on Tuesday reported third-quarter profit of $3.54 billion. On a per-share basis, the New York-based company said it had net income of 62 cents.",
    "url": "https://finance.yahoo.com/news/pfizer-q3-earnings-snapshot-120337557.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "29eb28d3-00af-3f8c-92d3-a145deeb78cb",
      "content": {
        "id": "29eb28d3-00af-3f8c-92d3-a145deeb78cb",
        "contentType": "STORY",
        "title": "Pfizer: Q3 Earnings Snapshot",
        "description": "",
        "summary": "NEW YORK (AP) — Pfizer Inc. PFE) on Tuesday reported third-quarter profit of $3.54 billion. On a per-share basis, the New York-based company said it had net income of 62 cents.",
        "pubDate": "2025-11-04T12:03:37Z",
        "displayTime": "2025-11-04T12:03:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-q3-earnings-snapshot-120337557.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-q3-earnings-snapshot-120337557.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T11:45:00+00:00",
    "headline": "Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance",
    "summary": "NEW YORK, November 04, 2025--Pfizer Q3-25 Earnings Release",
    "url": "https://finance.yahoo.com/news/pfizer-reports-solid-third-quarter-114500230.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "99d85bf1-1519-3540-954a-4b2f975737eb",
      "content": {
        "id": "99d85bf1-1519-3540-954a-4b2f975737eb",
        "contentType": "STORY",
        "title": "Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance",
        "description": "",
        "summary": "NEW YORK, November 04, 2025--Pfizer Q3-25 Earnings Release",
        "pubDate": "2025-11-04T11:45:00Z",
        "displayTime": "2025-11-04T11:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/a11448dc401e32edebd89817cbacc07c",
          "originalWidth": 480,
          "originalHeight": 212,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IfUkWBoq.qEYvgflXDcNEg--~B/aD0yMTI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a11448dc401e32edebd89817cbacc07c.cf.webp",
              "width": 480,
              "height": 212,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pL6o66A7gqvPi0c4HV_hnA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a11448dc401e32edebd89817cbacc07c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-reports-solid-third-quarter-114500230.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-reports-solid-third-quarter-114500230.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "1530.HK"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T11:36:00+00:00",
    "headline": "Metsera again chooses Novo as bidding war with Pfizer intensifies",
    "summary": "The obesity drug developer has declared a new proposal from Novo “superior” to Pfizer’s original bid as well as an updated offer revealed Tuesday.",
    "url": "https://www.biopharmadive.com/news/metsera-pfizer-novo-obesity-drugs-new-offers-superior-proposal/804598/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "3785abfe-8fa0-39f6-b124-24456fcf4c06",
      "content": {
        "id": "3785abfe-8fa0-39f6-b124-24456fcf4c06",
        "contentType": "STORY",
        "title": "Metsera again chooses Novo as bidding war with Pfizer intensifies",
        "description": "",
        "summary": "The obesity drug developer has declared a new proposal from Novo “superior” to Pfizer’s original bid as well as an updated offer revealed Tuesday.",
        "pubDate": "2025-11-04T11:36:00Z",
        "displayTime": "2025-11-04T11:36:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/a1c09bffc85a86faa929fd29b7aa9996",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Flags bearing Novo Nordisk's logo fly outside of one of the company's offices.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NoKr2xU4zK4L04qalInpLQ--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/a1c09bffc85a86faa929fd29b7aa9996.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/x10r341dFsCXcrMM0YqHxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/a1c09bffc85a86faa929fd29b7aa9996.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/metsera-pfizer-novo-obesity-drugs-new-offers-superior-proposal/804598/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/metsera-again-chooses-novo-bidding-113600668.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T09:29:00+00:00",
    "headline": "Global Markets Fall After Fed Officials Express Diverging Views on Cuts",
    "summary": "U.S. stock futures were in the red with earnings due later from Advanced Micro Devices, Uber, Pfizer and Thomson Reuters.",
    "url": "https://www.wsj.com/finance/global-markets-fall-after-fed-officials-express-diverging-views-on-cuts-91235ae9?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "806fef71-716a-3386-bee0-e48f57c76e1c",
      "content": {
        "id": "806fef71-716a-3386-bee0-e48f57c76e1c",
        "contentType": "STORY",
        "title": "Global Markets Fall After Fed Officials Express Diverging Views on Cuts",
        "description": "",
        "summary": "U.S. stock futures were in the red with earnings due later from Advanced Micro Devices, Uber, Pfizer and Thomson Reuters.",
        "pubDate": "2025-11-04T09:29:00Z",
        "displayTime": "2025-11-04T09:29:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/806fef71-716a-3386-bee0-e48f57c76e1c/global-markets-fall-after-fed.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/524873822577089acc24a57ebcd0799c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qiBa58YamTQaWwjnOiRtcg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/524873822577089acc24a57ebcd0799c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xefkSNpViG6M4dtL3AllgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/524873822577089acc24a57ebcd0799c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/finance/global-markets-fall-after-fed-officials-express-diverging-views-on-cuts-91235ae9?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMD"
            },
            {
              "symbol": "DX-Y.NYB"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T09:13:37+00:00",
    "headline": "McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week",
    "summary": "All eyes are on the government shutdown, which is nearing the longest on record. Meanwhile, investors will dig into earnings from McDonald’s, AMD and others. On Thursday, Tesla is due to publish the outcome of its shareholder vote on CEO Elon Musk’s pay package.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-04-2025/card/mcdonald-s-earnings-tariff-update-musk-pay-vote-what-to-watch-this-week-zZ6aBfR7OeFbvELoFeVP?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "76be8066-2dae-3737-b8c2-cd763025e8d4",
      "content": {
        "id": "76be8066-2dae-3737-b8c2-cd763025e8d4",
        "contentType": "STORY",
        "title": "McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week",
        "description": "",
        "summary": "All eyes are on the government shutdown, which is nearing the longest on record. Meanwhile, investors will dig into earnings from McDonald’s, AMD and others. On Thursday, Tesla is due to publish the outcome of its shareholder vote on CEO Elon Musk’s pay package.",
        "pubDate": "2025-11-04T09:13:37Z",
        "displayTime": "2025-11-04T09:13:37Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/76be8066-2dae-3737-b8c2-cd763025e8d4/mcdonald%E2%80%99s-earnings-tariff.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/3cc025271f1733774fc21432f24310e2",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IXHWufzVu7b9TaM47z1z9A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/3cc025271f1733774fc21432f24310e2.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y3pDdGT_FU_ab9L6OoDnLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/3cc025271f1733774fc21432f24310e2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-04-2025/card/mcdonald-s-earnings-tariff-update-musk-pay-vote-what-to-watch-this-week-zZ6aBfR7OeFbvELoFeVP?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCD"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "APO"
            },
            {
              "symbol": "MAR"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "7203.T"
            },
            {
              "symbol": "APP"
            },
            {
              "symbol": "DASH"
            },
            {
              "symbol": "VAC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T06:15:00+00:00",
    "headline": "Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea",
    "summary": "Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 04, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued strong sales performance of the antifungal Cresemba® (isavuconazole) by its license partner Pfizer Inc. in Europe exceeded the threshold triggering a USD 30 million sales milestone payment. David V",
    "url": "https://finance.yahoo.com/news/strong-cresemba-isavuconazole-sales-performance-061500130.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "6d2117b1-db9d-3d75-a983-8925e5aea9ee",
      "content": {
        "id": "6d2117b1-db9d-3d75-a983-8925e5aea9ee",
        "contentType": "STORY",
        "title": "Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea",
        "description": "",
        "summary": "Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 04, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the continued strong sales performance of the antifungal Cresemba® (isavuconazole) by its license partner Pfizer Inc. in Europe exceeded the threshold triggering a USD 30 million sales milestone payment. David V",
        "pubDate": "2025-11-04T06:15:00Z",
        "displayTime": "2025-11-04T06:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/ab6630399880cc3ea968f1a9f177a73c",
          "originalWidth": 2843,
          "originalHeight": 970,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xGCvKXGNRUXK1qBvfYMz9w--~B/aD05NzA7dz0yODQzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ab6630399880cc3ea968f1a9f177a73c.cf.webp",
              "width": 2843,
              "height": 970,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5Qni1lgxkLoNHyUl5nneBA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/ab6630399880cc3ea968f1a9f177a73c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/strong-cresemba-isavuconazole-sales-performance-061500130.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/strong-cresemba-isavuconazole-sales-performance-061500130.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BPMUF"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T05:00:26+00:00",
    "headline": "All megadeals lead to Washington",
    "summary": "One scoop to start: An influential group representing some of the private equity industry’s largest backers has sounded the alarm about the risks...",
    "url": "https://finance.yahoo.com/news/megadeals-lead-washington-050026265.html",
    "source": "Financial Times",
    "provider": "yfinance",
    "raw": {
      "id": "c6a6fe5a-80c9-38eb-9efd-0b511f60af41",
      "content": {
        "id": "c6a6fe5a-80c9-38eb-9efd-0b511f60af41",
        "contentType": "STORY",
        "title": "All megadeals lead to Washington",
        "description": "",
        "summary": "One scoop to start: An influential group representing some of the private equity industry’s largest backers has sounded the alarm about the risks...",
        "pubDate": "2025-11-04T05:00:26Z",
        "displayTime": "2025-11-04T05:00:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2024-02/c4199640-d66b-11ee-9f6e-85b4aafedb77",
          "originalWidth": 5472,
          "originalHeight": 3080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n2TDRfDbnr19djoUTiiCFQ--~B/aD0zMDgwO3c9NTQ3MjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2024-02/c4199640-d66b-11ee-9f6e-85b4aafedb77.cf.webp",
              "width": 5472,
              "height": 3080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9tY47GCzeeaIi_ivw8Tk.g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2024-02/c4199640-d66b-11ee-9f6e-85b4aafedb77.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Financial Times",
          "url": "https://www.ft.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/megadeals-lead-washington-050026265.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/megadeals-lead-washington-050026265.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "AVLL3.SA"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 11:10 p.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000721.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "c1fff03a-e0a9-3c9e-8660-5786a4828977",
      "content": {
        "id": "c1fff03a-e0a9-3c9e-8660-5786a4828977",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 11:10 p.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-04T05:00:00Z",
        "displayTime": "2025-11-04T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000721.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000721.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T05:00:00+00:00",
    "headline": "AP Top Financial News at 11:10 p.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000939.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "acf8e411-606f-30ce-9b16-a8e89a5e3393",
      "content": {
        "id": "acf8e411-606f-30ce-9b16-a8e89a5e3393",
        "contentType": "STORY",
        "title": "AP Top Financial News at 11:10 p.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-04T05:00:00Z",
        "displayTime": "2025-11-04T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000939.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000939.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T20:43:14+00:00",
    "headline": "Our Top November High-Yield Picks Pay Reliable 7%-9% Dividends",
    "summary": "Our five top November high-yield picks have solid forward momentum and should hold their ground well, even if we experience a 10% or bigger correction.",
    "url": "https://247wallst.com/investing/2025/11/04/our-top-november-high-yield-picks-pay-reliable-7-9-dividends/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "8ec9a5d8-9893-3054-9065-dd45d9e933e0",
      "content": {
        "id": "8ec9a5d8-9893-3054-9065-dd45d9e933e0",
        "contentType": "STORY",
        "title": "Our Top November High-Yield Picks Pay Reliable 7%-9% Dividends",
        "description": "",
        "summary": "Our five top November high-yield picks have solid forward momentum and should hold their ground well, even if we experience a 10% or bigger correction.",
        "pubDate": "2025-11-04T20:43:14Z",
        "displayTime": "2025-11-04T20:43:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/eaf2fd55c5c9896c07e4f214ae2d4bb1",
          "originalWidth": 1500,
          "originalHeight": 999,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/egbS_Q4rlVYbc0Yry0FaIQ--~B/aD05OTk7dz0xNTAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/eaf2fd55c5c9896c07e4f214ae2d4bb1.cf.webp",
              "width": 1500,
              "height": 999,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/un4.4BBEBLpBdrOsWxFBfA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/eaf2fd55c5c9896c07e4f214ae2d4bb1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/11/04/our-top-november-high-yield-picks-pay-reliable-7-9-dividends/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-november-high-yield-picks-204314008.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MO"
            },
            {
              "symbol": "ET"
            },
            {
              "symbol": "ET-PI"
            },
            {
              "symbol": "VZ"
            },
            {
              "symbol": "CTO"
            },
            {
              "symbol": "CTO-PA"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T15:59:49+00:00",
    "headline": "Pfizer & Novo boost Metsera bids, Hertz stock skyrockets",
    "summary": "Market Catalysts host Julie Hyman takes a closer look at some of the trending tickers during Tuesday's trading session. Pfizer (PFE) and Novo Nordisk (NVO) have boosted their bids to buy Metsera (MTSR). Sarepta (SRPT) stock nosedives after a drug trial failed. Hertz (HTZ) stock skyrockets after the company reported a surprise profit. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finance.yahoo.com/video/pfizer-novo-boost-metsera-bids-155949145.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "7010197a-5928-33e3-9eec-53cb52902f0d",
      "content": {
        "id": "7010197a-5928-33e3-9eec-53cb52902f0d",
        "contentType": "VIDEO",
        "title": "Pfizer & Novo boost Metsera bids, Hertz stock skyrockets",
        "description": "<p>Market Catalysts host <a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/author/julie-hyman/\">Julie Hyman</a> takes a closer look at some of the trending tickers during Tuesday's trading session.</p>\n<p>Pfizer (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>) and Novo Nordisk (<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/NVO\">NVO</a>) have boosted their bids to buy Metsera (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/MTSR\">MTSR</a>).</p>\n<p>Sarepta (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/SRPT\">SRPT</a>) stock nosedives after a drug trial failed.</p>\n<p>Hertz (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/HTZ\">HTZ</a>) stock skyrockets after the company reported a surprise profit.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-catalysts/\">Market Catalysts</a>.</p>",
        "summary": "Market Catalysts host Julie Hyman takes a closer look at some of the trending tickers during Tuesday's trading session. Pfizer (PFE) and Novo Nordisk (NVO) have boosted their bids to buy Metsera (MTSR). Sarepta (SRPT) stock nosedives after a drug trial failed. Hertz (HTZ) stock skyrockets after the company reported a surprise profit. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
        "pubDate": "2025-11-04T15:59:49Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/9d652590-b996-11f0-94ed-6d4f1ef86bed",
          "originalWidth": 5472,
          "originalHeight": 3081,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v3WdUDSf3Posrs0uYFbhXw--~B/aD0zMDgxO3c9NTQ3MjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/9d652590-b996-11f0-94ed-6d4f1ef86bed.cf.webp",
              "width": 5472,
              "height": 3081,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gHgGcIBuyUPZwSGNzSJZAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/9d652590-b996-11f0-94ed-6d4f1ef86bed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/pfizer-novo-boost-metsera-bids-155949145.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/pfizer-novo-boost-metsera-bids-155949145.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "HTZ"
            },
            {
              "symbol": "SRPT"
            },
            {
              "symbol": "HTZWW"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T14:12:24+00:00",
    "headline": "Palantir's post-earnings drag, Uber sinks, Pfizer earnings",
    "summary": "Morning Brief host Julie Hyman outlines three stories investors are watching on Tuesday, Nov. 4. US stock futures (ES=F, NQ=F, YM=F) are under pressure as Palantir (PLTR) stock weighs on the broader market after the company reported earnings results. Uber (UBER) and Pfizer (PFE) are also in focus following the companies' earnings. The ongoing US government shutdown is poised to be the longest ever. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finance.yahoo.com/video/palantirs-post-earnings-drag-uber-141224137.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "1e72771c-f114-3e71-937a-c1127087054c",
      "content": {
        "id": "1e72771c-f114-3e71-937a-c1127087054c",
        "contentType": "VIDEO",
        "title": "Palantir's post-earnings drag, Uber sinks, Pfizer earnings",
        "description": "<p>Morning Brief host <a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/author/julie-hyman/\">Julie Hyman</a> outlines three stories investors are watching on Tuesday, Nov. 4.</p>\n<p>US stock futures (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/ES%3DF\">ES=F</a>, <a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/quote/NQ%3DF\">NQ=F</a>, <a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/YM%3DF\">YM=F</a>) are under pressure as <a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/news/palantir-stock-falls-amid-valuation-concerns-despite-q4-outlook-beating-wall-street-estimates-182343664.html\">Palantir</a> (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/PLTR\">PLTR</a>) stock weighs on the broader market after the company reported earnings results.</p>\n<p>Uber (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/UBER\">UBER</a>) and Pfizer (<a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/quote/PFE\">PFE</a>) are also in focus following the companies' earnings.</p>\n<p>The ongoing US government shutdown is poised to be the longest ever.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:9;pos:1\" href=\"https://finance.yahoo.com/videos/series/morning-brief/\">Morning Brief</a>.</p>",
        "summary": "Morning Brief host Julie Hyman outlines three stories investors are watching on Tuesday, Nov. 4. US stock futures (ES=F, NQ=F, YM=F) are under pressure as Palantir (PLTR) stock weighs on the broader market after the company reported earnings results. Uber (UBER) and Pfizer (PFE) are also in focus following the companies' earnings. The ongoing US government shutdown is poised to be the longest ever. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
        "pubDate": "2025-11-04T14:12:24Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/d45a0c00-b987-11f0-aebf-55ddcc75add4",
          "originalWidth": 4772,
          "originalHeight": 2688,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/O2BIvk4kIPA726VqWYGrdA--~B/aD0yNjg4O3c9NDc3MjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/d45a0c00-b987-11f0-aebf-55ddcc75add4.cf.webp",
              "width": 4772,
              "height": 2688,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/S667OmZAkb6jLHpqBTYnCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/d45a0c00-b987-11f0-aebf-55ddcc75add4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/palantirs-post-earnings-drag-uber-141224137.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/palantirs-post-earnings-drag-uber-141224137.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "ES=F"
            },
            {
              "symbol": "NQ=F"
            },
            {
              "symbol": "YM=F"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T16:45:49+00:00",
    "headline": "Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo",
    "summary": "WILMINGTON, Del.",
    "url": "https://ca.finance.yahoo.com/news/delaware-judge-does-not-see-164549127.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "a461ba2c-d8d4-384a-a092-12a268490269",
      "content": {
        "id": "a461ba2c-d8d4-384a-a092-12a268490269",
        "contentType": "STORY",
        "title": "Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo",
        "description": "",
        "summary": "WILMINGTON, Del.",
        "pubDate": "2025-11-04T16:45:49Z",
        "displayTime": "2025-11-04T16:45:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/699686d8f6271eef356432ae78c8e4a1",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California, U.S., September 30, 2025. REUTERS/Mike Blake/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4kQA.YhKzqlbz7KtR6_fCQ--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/699686d8f6271eef356432ae78c8e4a1.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QoLsVgmIMeam6o7VVDTqaw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/699686d8f6271eef356432ae78c8e4a1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/delaware-judge-does-not-see-164549127.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/delaware-judge-does-not-see-164549127.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-04T16:23:47+00:00",
    "headline": "Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up",
    "summary": "(Amends paragraph 6 after Metsera corrects Novo's previous CVR offer to $21.25 from $22.50) (Reuters) -Novo Nordisk and Pfizer have revised their bids for Metsera, the obesity drug developer said on",
    "url": "https://ca.finance.yahoo.com/news/novo-nordisk-pfizer-sweeten-bid-162347365.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "1e2b86a0-d4a0-3090-96f1-8e523b1ae21f",
      "content": {
        "id": "1e2b86a0-d4a0-3090-96f1-8e523b1ae21f",
        "contentType": "STORY",
        "title": "Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up",
        "description": "",
        "summary": "(Amends paragraph 6 after Metsera corrects Novo's previous CVR offer to $21.25 from $22.50) (Reuters) -Novo Nordisk and Pfizer have revised their bids for Metsera, the obesity drug developer said on",
        "pubDate": "2025-11-04T16:23:47Z",
        "displayTime": "2025-11-04T16:23:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/b1cc964fd87f09348f6b7c4e913a722c",
          "originalWidth": 800,
          "originalHeight": 483,
          "caption": "Danish drugmaker Novo Nordisk's logo above the entrance to their offices in Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_RtzFsV95vrtat8DFPgu4A--~B/aD00ODM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/b1cc964fd87f09348f6b7c4e913a722c.cf.webp",
              "width": 800,
              "height": 483,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/goLP4zvqeHXJoYQ7pT6oxw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/b1cc964fd87f09348f6b7c4e913a722c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/novo-nordisk-pfizer-sweeten-bid-162347365.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-pfizer-sweeten-bid-162347365.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]